LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects.

Miller, Ann K / Harrell, Emma / Ye, Li / Baptiste-Brown, Sharon / Kleim, Jőrg-Peter / Ohrt, Colin / Duparc, Stephan / Möhrle, Jörg J / Webster, Alison / Stinnett, Sandra / Hughes, Arlene / Griffith, Sandy / Beelen, Andrew P

British journal of clinical pharmacology

2013  Volume 76, Issue 6, Page(s) 858–867

Abstract: ... pharmacodynamic interactions were observed with coadministered CQ and TQ in healthy subjects. ... interaction and for pharmacodynamic, safety and tolerability characteristics.: Methods: Healthy subjects ... Aims: The long-acting 8-aminoquinoline tafenoquine (TQ) coadministered with chloroquine (CQ ...

Abstract Aims: The long-acting 8-aminoquinoline tafenoquine (TQ) coadministered with chloroquine (CQ) may radically cure Plasmodium vivax malaria. Coadministration therapy was evaluated for a pharmacokinetic interaction and for pharmacodynamic, safety and tolerability characteristics.
Methods: Healthy subjects, 18-55 years old, without documented glucose-6-phosphate dehydrogenase deficiency, received CQ alone (days 1-2, 600 mg; and day 3, 300 mg), TQ alone (days 2 and 3, 450 mg) or coadministration therapy (day 1, CQ 600 mg; day 2, CQ 600 mg + TQ 450 mg; and day 3, CQ 300 mg + TQ 450 mg) in a randomized, double-blind, parallel-group study. Blood samples for pharmacokinetic and pharmacodynamic analyses and safety data, including electrocardiograms, were collected for 56 days.
Results: The coadministration of CQ + TQ had no effect on TQ AUC0-t , AUC0-∞ , Tmax or t1/2 . The 90% confidence intervals of CQ + TQ vs. TQ for AUC0-t , AUC0-∞ and t1/2 indicated no drug interaction. On day 2 of CQ + TQ coadministration, TQ Cmax and AUC0-24 increased by 38% (90% confidence interval 1.27, 1.64) and 24% (90% confidence interval 1.04, 1.46), respectively. The pharmacokinetics of CQ and its primary metabolite desethylchloroquine were not affected by TQ. Coadministration had no clinically significant effect on QT intervals and was well tolerated.
Conclusions: No clinically significant safety or pharmacokinetic/pharmacodynamic interactions were observed with coadministered CQ and TQ in healthy subjects.
MeSH term(s) Administration, Oral ; Adolescent ; Adult ; Aminoquinolines/administration & dosage ; Aminoquinolines/adverse effects ; Aminoquinolines/pharmacokinetics ; Antimalarials/administration & dosage ; Antimalarials/adverse effects ; Antimalarials/pharmacokinetics ; Area Under Curve ; Chloroquine/administration & dosage ; Chloroquine/adverse effects ; Chloroquine/pharmacokinetics ; Double-Blind Method ; Drug Interactions ; Drug Therapy, Combination ; Female ; Glucosephosphate Dehydrogenase/genetics ; Glucosephosphate Dehydrogenase/metabolism ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Young Adult
Chemical Substances Aminoquinolines ; Antimalarials ; tafenoquine (262P8GS9L9) ; Chloroquine (886U3H6UFF) ; Glucosephosphate Dehydrogenase (EC 1.1.1.49)
Language English
Publishing date 2013-05-23
Publishing country England
Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
ZDB-ID 188974-6
ISSN 1365-2125 ; 0306-5251 ; 0264-3774
ISSN (online) 1365-2125
ISSN 0306-5251 ; 0264-3774
DOI 10.1111/bcp.12160
Shelf mark
Zs.A 1118: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top